ES2763946T3 - Formas estereoisoméricas aisladas de (S) 2-N (3-O-(propano 2-ol)-1-propilo-4-hidroxibenceno)-3-fenilpropilamida - Google Patents
Formas estereoisoméricas aisladas de (S) 2-N (3-O-(propano 2-ol)-1-propilo-4-hidroxibenceno)-3-fenilpropilamida Download PDFInfo
- Publication number
- ES2763946T3 ES2763946T3 ES12855522T ES12855522T ES2763946T3 ES 2763946 T3 ES2763946 T3 ES 2763946T3 ES 12855522 T ES12855522 T ES 12855522T ES 12855522 T ES12855522 T ES 12855522T ES 2763946 T3 ES2763946 T3 ES 2763946T3
- Authority
- ES
- Spain
- Prior art keywords
- pain
- compound
- study
- phenylpropylamide
- hydroxybenzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568219P | 2011-12-08 | 2011-12-08 | |
| PCT/IL2012/050512 WO2013084238A1 (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2763946T3 true ES2763946T3 (es) | 2020-06-01 |
Family
ID=48573665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12855522T Active ES2763946T3 (es) | 2011-12-08 | 2012-12-06 | Formas estereoisoméricas aisladas de (S) 2-N (3-O-(propano 2-ol)-1-propilo-4-hidroxibenceno)-3-fenilpropilamida |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9381173B2 (https=) |
| EP (1) | EP2788317B1 (https=) |
| JP (2) | JP6411893B2 (https=) |
| CN (1) | CN103998420B (https=) |
| AU (1) | AU2012348529B2 (https=) |
| CA (1) | CA2856665C (https=) |
| DK (1) | DK2788317T3 (https=) |
| ES (1) | ES2763946T3 (https=) |
| HU (1) | HUE048570T2 (https=) |
| IN (1) | IN2014MN00919A (https=) |
| WO (1) | WO2013084238A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173813A1 (en) * | 2014-05-14 | 2015-11-19 | Novaremed Ltd. | Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes |
| KR102062268B1 (ko) | 2018-05-18 | 2020-01-03 | 한국교통대학교 산학협력단 | 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제 |
| CN113329746B (zh) * | 2019-01-23 | 2025-05-02 | 诺瓦麦有限公司 | 用于治疗或预防疼痛、炎症和/或自身免疫的化合物 |
| EP3939578A1 (en) | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
| WO2026037478A1 (en) | 2023-08-11 | 2026-02-19 | Novaremed AG | (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1546088B1 (en) | 2002-10-03 | 2014-12-17 | Novaremed Ltd. | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| JP4939396B2 (ja) | 2004-03-26 | 2012-05-23 | ノヴァレメッド リミテッド | Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法 |
| US20090197781A1 (en) | 2008-01-31 | 2009-08-06 | Hari Babu Sunkara | Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers |
| GB0804213D0 (en) * | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| US8802734B2 (en) * | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| EP2475361B1 (en) | 2009-09-09 | 2019-11-06 | Novaremed Ltd. | N-substituted benzenepropanamides for use in the treatment of pain and inflammation |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
-
2012
- 2012-12-06 DK DK12855522.4T patent/DK2788317T3/da active
- 2012-12-06 ES ES12855522T patent/ES2763946T3/es active Active
- 2012-12-06 EP EP12855522.4A patent/EP2788317B1/en active Active
- 2012-12-06 CN CN201280060570.9A patent/CN103998420B/zh active Active
- 2012-12-06 CA CA2856665A patent/CA2856665C/en active Active
- 2012-12-06 AU AU2012348529A patent/AU2012348529B2/en active Active
- 2012-12-06 WO PCT/IL2012/050512 patent/WO2013084238A1/en not_active Ceased
- 2012-12-06 HU HUE12855522A patent/HUE048570T2/hu unknown
- 2012-12-06 JP JP2014545450A patent/JP6411893B2/ja active Active
-
2014
- 2014-05-16 IN IN919MUN2014 patent/IN2014MN00919A/en unknown
- 2014-05-30 US US14/291,901 patent/US9381173B2/en active Active
-
2017
- 2017-07-21 JP JP2017142137A patent/JP2018021023A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012348529B2 (en) | 2017-03-30 |
| HK1201059A1 (en) | 2015-08-21 |
| EP2788317B1 (en) | 2019-10-02 |
| WO2013084238A1 (en) | 2013-06-13 |
| DK2788317T3 (da) | 2020-01-20 |
| JP2015500831A (ja) | 2015-01-08 |
| EP2788317A4 (en) | 2015-07-08 |
| US9381173B2 (en) | 2016-07-05 |
| IN2014MN00919A (https=) | 2015-04-17 |
| CA2856665A1 (en) | 2013-06-13 |
| CN103998420A (zh) | 2014-08-20 |
| US20140275270A1 (en) | 2014-09-18 |
| JP2018021023A (ja) | 2018-02-08 |
| AU2012348529A1 (en) | 2014-06-12 |
| JP6411893B2 (ja) | 2018-10-31 |
| CN103998420B (zh) | 2018-04-17 |
| HUE048570T2 (hu) | 2020-08-28 |
| CA2856665C (en) | 2019-11-12 |
| EP2788317A1 (en) | 2014-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Power | Recent advances in postoperative pain therapy | |
| EP0934061B1 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| ES2763946T3 (es) | Formas estereoisoméricas aisladas de (S) 2-N (3-O-(propano 2-ol)-1-propilo-4-hidroxibenceno)-3-fenilpropilamida | |
| Urban et al. | In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue | |
| JP2013056918A (ja) | グリシン捕捉性アンタゴニストを用いる拒絶性および認知性精神分裂病症候群の処置 | |
| US3035974A (en) | Compositions and method for the parenteral administration of thyroxine | |
| Haghparast et al. | Changes in phosphorylation of CREB, ERK, and c-fos induction in rat ventral tegmental area, hippocampus and prefrontal cortex after conditioned place preference induced by chemical stimulation of lateral hypothalamus | |
| US7632825B2 (en) | Methods of decreasing or preventing pain using spicamycin derivatives | |
| US20250082688A1 (en) | Compositions and methods for williams syndrome (ws) therapy | |
| Wei et al. | Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization | |
| US6518311B2 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
| US20090298864A1 (en) | Methods for Treating Mild Cognitive Impairment | |
| Kim et al. | Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study | |
| Longmire et al. | Topics in clinical pharmacology: flumazenil, a benzodiazepine antagonist | |
| WO2006017614A1 (en) | Use of n-desmethylclozapine to treat human neuropsychiatric disease | |
| WO2018119065A1 (en) | Use of histone methyltransferase inhibitors and histone deacetylase inhibitors for therapy of phelan-mcdermid syndrome | |
| WO2020061636A1 (en) | Treatment of neuropathic pain | |
| Kundu et al. | The study of analgesic activity of complexes of magnesium sulfate with aspirin, paracetamol and naproxen | |
| HK1201059B (en) | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide | |
| WO2026082992A1 (es) | Derivados de sulfamida para el trastorno por uso de alcohol | |
| Sato et al. | Inhibitory effect of various traditional Chinese medicines on rabbit platelet phospholipase A2 in vitro and suppressive effect of toki-syakuyaku-san on increased aggregability in hypercholesterolemic rabbit ex vivo | |
| CN1277019A (zh) | 增强大脑乙酰胆碱释放的药剂 | |
| HK1116664A (en) | Use of n-desmethylclozapine to treat human neuropsychiatric disease | |
| BRPI1103978A2 (pt) | composiÇÕes e mÉtodos para tratar sÍndorme mielodisplÁsica |